Ancillary testing for bladder cancer screening and detection
HAYES, Inc.
Record ID 32004000354
English
Authors' objectives:
Ancillary urine tests detect different substances that are associated with tumors such as tumor antigens, cellular proteins, and DNA abnormalities. The test results are used in conjunction with cystoscopy, the current standard diagnostic procedure for bladder cancer, for the early detection of bladder cancer in patients: (1) who present with clinical signs and symptoms; (2) who are at high risk to develop bladder cancer; or (3) who require monitoring for bladder cancer recurrence after surgery.
Authors' methods:
Review
Details
Project Status:
Completed
URL for project:
http://www.hayesinc.com/
Year Published:
2004
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Urinalysis
- Urinary Bladder Neoplasms
- Mass Screening
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.